<DOC>
	<DOC>NCT02544906</DOC>
	<brief_summary>The use of propofol or dexmedetomedine for prevention of sevofurane emergence agitation in LDLT recipients</brief_summary>
	<brief_title>Propofol Versus Dexmedetomidine for Prevention of Sevoflurane Agitation in Recipients of Living Donor Liver Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<criteria>All recipients of living donor liver transplantation patient refusal Allergy to either propofol or dexmedetomediene CNS disease</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>recipients</keyword>
</DOC>